BTMD
biote Corp.
NasdaqGMUSDEQUITY
DELAYED
Last price
1.60
▲ 0.12 (8.11%)
MARKET · —
Price
Open
1.47
Prev close
1.48
Day high
1.62
Day low
1.48
Volume
274.54K
Market cap
—
P/E (TTM)
—
52W range
1.27 – 3.62
Trailing performance
Returnvs SPY
1W
+9.52%
+10.9%
1M
-28.44%
-32.2%
3M
-22.22%
-25.3%
6M
-23.33%
-34.4%
YTD
-38.08%
-50.4%
1Y
-45.79%
-65.8%
3Y
-68.86%
-143.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.46
+9.74% from price
SMA 20
1.78
-9.53% from price
SMA 50
2.04
-21.23% from price
SMA 100
2.04
-21.42% from price
SMA 200
2.15
-25.20% from price
EMA 12
1.57
+1.79% from price
EMA 26
1.78
-9.95% from price
EMA 50
1.92
-16.84% from price
RSI (14)
43.1
Neutral
MACD (12,26,9)
-0.21
Hist -0.02
ATR (14)
0.19
11.58% of price
Realised vol 30D
124.6%
Annualised
Bollinger upper
2.55
20, 2σ
Bollinger lower
1.01
20, 2σ
50 / 200 cross
Death
2.04 vs 2.15
Trend bias
Below 200
-25.20%
Risk profile
Beta vs SPY
1.31
More volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
124.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-62.8%
Peak to trough
Max drawdown 5Y
-87.1%
Peak to trough
ATR 14
0.19
11.58% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Biote Corp (BTMD) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges and ...
GuruFocus.com · 17d ago
biote Corp. (BTMD) Reports Break-Even Earnings for Q2
Zacks · 17d ago
biote Q2 Earnings Call Highlights
MarketBeat · 17d ago
Earnings To Watch: Biote Corp (BTMD) Q2 2026 -- GF Value Sees 39% Upside
GuruFocus.com · 18d ago
Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call
Business Wire · 31d ago
How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations
Simply Wall St. · 78d ago
Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
Business Wire · 82d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.